Alcresta Therapeutics
Phase 3Enzyme products designed for enteral nutrition
Founded
2011
Focus
MetabolicRare DiseaseDrug Delivery
About
Enzyme products designed for enteral nutrition
Funding History
4Total raised: $178M
Debt$50MPerceptive AdvisorsJun 15, 2020
Series C$72MPerceptive AdvisorsJun 15, 2018
Series B$36MFrazier Healthcare PartnersJun 15, 2016
Series A$20MThird Rock VenturesJun 15, 2014
Company Info
TypePrivate
Founded2011
LocationNewton, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile